NCT03713996

Brief Summary

Insomnia is a common sleep disorder, with three main symptoms: difficulty in initiating sleep, difficulty in maintaining sleep, and/or waking up early without ability to return to sleep. Insomnia can contribute to metabolic dysfunction, which can lead to type 2 diabetes (T2D). Diabetes self-care behavior (DSCB) is important in attaining and maintaining glycemic control, which worsens as a result of fatigue. People with insomnia usually suffer from fatigue and inconstant sleep schedule, which negatively influence quality of life. However, the additive effect of behavioral sleep intervention on diabetes outcomes and health status in people with T2D is unknown. Therefore, The overall purpose of this study is to investigate the impact of both insomnia symptoms and CBT-I on people with T2D. The central hypotheses are that people with T2D and insomnia symptoms will have worse sleep, diabetes measures and self-reported outcomes compared to people with T2D only, which might be adjusted with CBT-I.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
28

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2019

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 11, 2018

Completed
11 days until next milestone

First Posted

Study publicly available on registry

October 22, 2018

Completed
3 months until next milestone

Study Start

First participant enrolled

January 16, 2019

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2019

Completed
Last Updated

August 28, 2019

Status Verified

August 1, 2019

Enrollment Period

5 months

First QC Date

October 11, 2018

Last Update Submit

August 26, 2019

Conditions

Keywords

Cognitive Behavioral Therapy for InsomniaSelf-CareFatigueDiabetesGlycemic Control

Outcome Measures

Primary Outcomes (1)

  • Change in Insomnia Severity Index

    The Insomnia Severity Index is a self-report measure designed to evaluate the nature, severity, and impact of insomnia.Seven-items assess severity of sleep onset, sleep maintenance, early morning awakening problems, sleep dissatisfaction, interference of sleep difficulties with daytime functioning, noticeability of sleep problems by others, and distress due to the sleep difficulties.This is self-reported seven items on a five-point Likert scale from zero (not at all satisfied) to four (very much satisfied). Total scores range from 0 to 28, with higher scores indicating greater insomnia severity.

    Insomnia severity will be assessed at the baseline and 8 weeks.

Secondary Outcomes (14)

  • Change in the Variability of Total Sleep Time in Minutes using Objective Measure, Actigraph

    The variability of total sleep time for 7 nights will be assessed at the baseline and 8 weeks.

  • Change in the Variability of Wake after Sleep Onset in Minutes using Objective Measure, Actigraph

    The variability of wake after sleep onset for 7 nights will be assessed at the baseline and 8 weeks.

  • Change in the Variability of Sleep Latency in Minutes using Objective Measure, Actigraph

    The variability of sleep latency for 7 nights will be assessed at the baseline and 8 weeks.

  • Change in the Variability of Sleep Efficiency using Objective Measure, Actigraph

    The variability of sleep efficiency for 7 nights will be assessed at the baseline and 8 weeks.

  • Change in the Variability of Total Sleep Time in Minutes using Subjective Measure, Sleep Diary

    The variability of total sleep time for 7 nights will be assessed at the baseline and 8 weeks.

  • +9 more secondary outcomes

Study Arms (2)

CBT-I intervention

EXPERIMENTAL

The intervention includes several face-to-face interview techniques: sleep restriction therapy, stimulus control procedures, sleep hygiene, relaxation training and cognitive components.

Behavioral: Cognitive behavioral therapy for insomnia

Diabetes Education

ACTIVE COMPARATOR

Sleep hygiene, foot care, causes and diagnosis of diabetes, healthy diet, and physical activity will be delivered for the Health Education group. During all sessions, subjects will be encouraged to engage in the discussion through open questions about their experience in diabetes, lifestyle, and understanding about provided materials.

Other: Health Education

Interventions

CBT-I is designed to change sleep habits as well as direct misconceptions about sleep and insomnia. Participants will receive several face-to-face interview techniques: sleep restriction therapy, stimulus control procedures, sleep hygiene, relaxation training and cognitive components. The intervention will be provided in 6-session (one session/week).

CBT-I intervention

Participants in this arm will receive education in sleep hygiene, foot care, causes and diagnosis of diabetes, healthy diet, and physical activity. The education will be provided in 6-session (1 session/week).

Diabetes Education

Eligibility Criteria

Age40 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age between 40 to 75 years
  • Self-reported diagnosis of type 2 diabetes
  • Insomnia Severity Index \>10 and self-reported symptoms of insomnia at least 3 nights/week for the past 3 months for insomnia and type 2 diabetes group
  • Insomnia Severity Index ≤10 for type 2 diabetes only group
  • Able to attend 6 sessions
  • Able to understand and follow verbal commands in English
  • Able to travel to our lab

You may not qualify if:

  • Self-reported neurological diseases (e.g. Alzheimer's disease, Parkinson's disease, Traumatic Brain Injury, Stroke, Multiple Sclerosis)
  • Stop-Bang \> 4 indicating severe risk of sleep apnea
  • Failure to pass Restless Leg Syndrome Diagnostic Index
  • Severe pain ≥ 7 out of 10 on Brief Pain Inventory
  • Severe symptom level of depression scores ≥ 21 on Beck Depression Inventory
  • Severe symptom level of anxiety scores ≥ 15 on Generalized Anxiety Scale-7
  • Pregnant women
  • Self-reported following medical issues: Chronic Fatigue Syndrome, Fibromyalgia, and Rheumatic Diseases
  • Speech deficits or significant auditory impairment
  • Night-shift work
  • Self-reported Bipolar and Seizure Disorders
  • Heavy alcohol drinker (≥15 drinks per week for men and ≥ 8 drinks per week for women)
  • Dialysis/blindness/trans-femoral amputation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Kansas Medical Center

Kansas City, Kansas, 66160, United States

Location

Related Publications (2)

  • Alshehri MM, Alothman SA, Alenazi AM, Rucker JL, Phadnis MA, Miles JM, Siengsukon CF, Kluding PM. The effects of cognitive behavioral therapy for insomnia in people with type 2 diabetes mellitus, pilot RCT part II: diabetes health outcomes. BMC Endocr Disord. 2020 Sep 5;20(1):136. doi: 10.1186/s12902-020-00612-6.

  • Alshehri MM, Alenazi AM, Hoover JC, Alothman SA, Phadnis MA, Rucker JL, Befort CA, Miles JM, Kluding PM, Siengsukon CF. Effect of Cognitive Behavioral Therapy for Insomnia on Insomnia Symptoms for Individuals With Type 2 Diabetes: Protocol for a Pilot Randomized Controlled Trial. JMIR Res Protoc. 2019 Dec 19;8(12):e14647. doi: 10.2196/14647.

MeSH Terms

Conditions

Sleep Initiation and Maintenance DisordersFatigueDiabetes Mellitus

Interventions

Cognitive Behavioral Therapy

Condition Hierarchy (Ancestors)

Sleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesMental DisordersSigns and SymptomsPathological Conditions, Signs and SymptomsGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Intervention Hierarchy (Ancestors)

Behavior TherapyPsychotherapyBehavioral Disciplines and Activities

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor and Chair, Department of Physical Therapy and Rehabilitation Science

Study Record Dates

First Submitted

October 11, 2018

First Posted

October 22, 2018

Study Start

January 16, 2019

Primary Completion

June 1, 2019

Study Completion

June 1, 2019

Last Updated

August 28, 2019

Record last verified: 2019-08

Data Sharing

IPD Sharing
Will share

The protocol of this study will be published. We already submit the protocol to an Open access journal.

Shared Documents
STUDY PROTOCOL, SAP, CSR
Time Frame
The protocol will be submitted to an open access journal and will be available to everyone.

Locations